Univ. Prof. Dr. Christoph Zielinski
Univ.-Prof. Dr. Christoph Zielinski is a leading oncologist and Medical Director of the Wiener Privatklinik. He specializes in the treatment of solid tumors and is regarded as one of the most renowned experts in the field of internal oncology in Europe. At the Wiener Privatklinik, he leads the Central European Cancer Center and sets standards in personalized cancer therapy and interdisciplinary collaboration.
Qualifications
Doctorate in Medicine from the University of Vienna (1976) Specialist training in Internal Medicine and Clinical Immunology Habilitation in Clinical Immunology (1986) and Internal Medicine (1988) Professor of Clinical-Experimental Oncology (since 1992)
Experience
Research fellow at the Cancer Research Center of Tufts University, Boston, USA (1979–1981) Head of the Clinical Department of Oncology at the Medical University of Vienna (2002–2017) Chair of the University Clinic for Internal Medicine I, Medical University of Vienna (2004–2017) Head of the Comprehensive Cancer Center (CCC) Vienna (2010–2018) President of the Central European Cooperative Oncology Group (CECOG) since 1999 Medical Director of the Wiener Privatklinik since 2020
Publications
Prof. Zielinski has published over 600 scientific papers and review articles in prestigious journals. His research is globally recognized and has led to more than 19,000 citations. His h-index is 67. This year, he is again listed among the leading oncologists in the Stanford List of Top Scientists worldwide, confirming his outstanding expertise and influence on cancer research.
Membership
European Society for Medical Oncology (ESMO), member of the Executive Board and former Chair of the Fellowships and Awards Committee American Society of Clinical Oncology (ASCO) American Association for Cancer Research (AACR) Chinese Society for Clinical Oncology (CSCO) Austrian Society for Hematology and Oncology Prof. Zielinski is also actively involved as the Editor-in-Chief of the open-access journal ESMO Open – Cancer Horizons and is an active member of the ESMO Council, where he plays a key role in the development of oncology standards.